An update on the pharmacotherapy of attention-deficit/hyperactivity disorder in adults - Wikidata - wikimedia - TriplyDB

An update on the pharmacotherapy of attention-deficit/hyperactivity disorder in adults

An update on the pharmacotherapy of attention-deficit/hyperactivity disorder in adults

http://www.wikidata.org/entity/Q34220004

about

ADHD medications and risk of serious cardiovascular events in young and middle-aged adults.Optimal management of ADHD in older adults Is Adult Attention-Deficit Hyperactivity Disorder Being Overdiagnosed?The complicated relationship between attention deficit/hyperactivity disorder and substance use disorders Agonist replacement for stimulant dependence: a review of clinical research Clinical practice: Adult attention deficit-hyperactivity disorder Pharmacotherapy for attention-deficit/hyperactivity disorder: from cells to circuits.Electrical coupling between the human serotonin transporter and voltage-gated Ca(2+) channels.Open-label dose optimization of methylphenidate modified release long acting (MPH-LA): a post hoc analysis of real-life titration from a 40-week randomized trial.The neurobiology of modafinil as an enhancer of cognitive performance and a potential treatment for substance use disorders.Methylphenidate for attention deficit hyperactivity disorder and drug relapse in criminal offenders with substance dependence: a 24-week randomized placebo-controlled trial Anxiety and Depressed Mood Decline Following Smoking Abstinence in Adult Smokers with Attention Deficit Hyperactivity Disorder.A candidate gene investigation of methylphenidate response in adult attention-deficit/hyperactivity disorder patients: results from a naturalistic study.Real-World Dosing Patterns of Atomoxetine in Adults with Attention-Deficit/Hyperactivity Disorder A review of the efficacy of atomoxetine in the treatment of attention-deficit hyperactivity disorder in children and adult patients with common comorbidities.Pharmacological and clinical dilemmas of prescribing in co-morbid adult attention-deficit/hyperactivity disorder and addiction.Atomoxetine for attention deficit hyperactivity disorder in the adulthood: a meta-analysis and meta-regression.Aiming for remission in adults with attention-deficit/hyperactivity disorder: The primary care goal.Oxidative and nitrosative stress in ADHD: possible causes and the potential of antioxidant-targeted therapies.Executive Functioning Outcomes Over 6 Months of Atomoxetine for Adults With ADHD: Relationship to Maintenance of Response and Relapse Over the Subsequent 6 Months After Treatment.Pharmacotherapy for parents with attention-deficit hyperactivity disorder (ADHD): impact on maternal ADHD and parenting.Methylphenidate facilitates hypnotizability in adults with ADHD: a naturalistic cohort study.Managing the comorbidity of schizophrenia and ADHD.Long-term functional outcome in adult prison inmates with ADHD receiving OROS-methylphenidate.ADHD and criminality: could treatment benefit prisoners with ADHD who are at higher risk of reoffending?Long-term safety and tolerability of atomoxetine in Japanese adults with attention deficit hyperactivity disorder.A nationwide study of attention-deficit/hyperactivity disorder drug use among adults in Iceland 2003-2012.Analgesia and Sedation Requirements in Mechanically Ventilated Trauma Patients With Acute, Preinjury Use of Cocaine and/or Amphetamines.Medication use in adults with attention deficit/hyperactivity disorder in a commercially-insured population in the United States.Psychopharmacological treatment of ADHD in adults aged 50+: an empirical study.Does pharmacological treatment of ADHD in adults enhance parenting performance? Results of a double-blind randomized trial.[Minimal cerebral dysfunctions and ADHD in adulthood].Exocytosis-related genes and response to methylphenidate treatment in adults with ADHD.Latent inhibition in ADHD adults on and off medication: a preliminary study.Patterns and profiles of Methylphenidate use in both children and adults.Treatment patterns, health care resource utilization, and costs in Japanese adults with attention-deficit hyperactivity disorder treated with atomoxetine.

P2860

Q22253017-C112531E-C003-481D-81BA-6BCF2AB4553D Q26774425-48EFB143-C397-42B8-AC0B-641A0AD95C27 Q26801761-F85564A0-1064-46DC-8A84-826598AB5D67 Q26851607-308A7048-B75C-4287-B58B-5E0EA16EBA65 Q27014854-DC44CD44-AFD7-4671-8EDA-B9DBC3072518 Q27027395-B46B95BD-DE08-4FAF-A16B-750ECDE7DE0B Q27687469-7ADC5E45-5E30-4472-867F-E60C0663ED23 Q33736971-33056062-650A-4313-B01A-375944827332 Q34085116-86A3E604-938A-43F5-806A-7170F63DD6B2 Q34363257-84C54BD9-F1A2-42BD-A483-87D9C4D44215 Q34481951-63662A8F-90CA-4934-A509-08CFD2675537 Q36322567-3C9F5B00-874C-42FD-B6B9-4BD9658B0369 Q37143837-8BEA5CBD-1959-4EDA-B6A0-929F8B637CC2 Q37308847-D6CEFA90-63C4-4564-B54F-D405A1FBD978 Q37638740-92D218A2-21A4-4C1D-8EAA-608D1F4376F6 Q38065287-BB196623-67D3-4D2B-9AF0-798D47BCDA0C Q38118231-C8645EF4-582D-455A-B7B9-E5C353476244 Q38348042-0963F6DF-B025-41DF-8AD9-B964369E3351 Q38430387-1F68D3DC-0BCE-4683-BC4E-758CA68E0E64 Q39493220-026F555A-B94D-46F4-A795-D72126D8ECEB Q39610434-B8D2C129-25F7-452E-A7B2-ABF0C0E00704 Q40935999-D1311340-2621-46E4-A8DB-89C3BCE69EED Q41000600-1C1C5358-8CE5-4FF4-86C9-B739EB01F371 Q41436769-71B9F0B0-7BF2-4631-90BD-F3BEDFB98029 Q44438827-74B2FAA4-9096-43B9-BDFC-D59A7E07F1D0 Q45752906-D7C48397-D145-487E-88F1-D32FDB43EF7F Q46622605-1B814567-8F91-43EE-B9B3-8E48AB0C6E1C Q47340863-96CC136B-6754-4AF5-9E60-EA95581F1C25 Q47571549-8297DF71-3575-462D-B082-B1F2A807FBEE Q48081594-7AA37BD6-5903-49FB-ACA4-6BBE7A7E4201 Q48108929-A4143088-FB02-486F-A36B-D7B06E6842B7 Q50537553-10565C94-EC2F-4F59-A6B8-652A6D4C1278 Q50684186-CE1A99EF-B6CC-433F-B17E-071052B21931 Q50754880-163F6B1B-EA82-483C-9DB4-B8CFBB835D1D Q51411756-B0606D98-CF8C-45EA-A9F4-F3CC7F540F00 Q52674905-0EE3A90D-BC08-4AED-86E8-1AE67116582F

P2860

An update on the pharmacotherapy of attention-deficit/hyperactivity disorder in adults

http://www.wikidata.org/entity/Q34220004

description

2011 nî lūn-bûn

@nan

2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

An update on the pharmacotherapy of attention-deficit/hyperactivity disorder in adults

@ast

An update on the pharmacotherapy of attention-deficit/hyperactivity disorder in adults

@en

An update on the pharmacotherapy of attention-deficit/hyperactivity disorder in adults

@nl

type

label

An update on the pharmacotherapy of attention-deficit/hyperactivity disorder in adults

@ast

An update on the pharmacotherapy of attention-deficit/hyperactivity disorder in adults

@en

An update on the pharmacotherapy of attention-deficit/hyperactivity disorder in adults

@nl

prefLabel

An update on the pharmacotherapy of attention-deficit/hyperactivity disorder in adults

@ast

An update on the pharmacotherapy of attention-deficit/hyperactivity disorder in adults

@en

An update on the pharmacotherapy of attention-deficit/hyperactivity disorder in adults

@nl

P1433

Q34220004-6615AEC2-F8EE-494D-9341-9B2840DE4A3F

P1476

Q34220004-75AD2A7F-BB53-451C-9C8E-8A2A7FA7908D

P2093

Q34220004-58625B65-2638-4C02-A3F9-6B9CDBBED164

Q34220004-B01E54FD-6FAC-41E2-96DA-A96211815771

Q34220004-EC7156BD-3829-490E-B545-7952F982264F

P2860

Q34220004-04F09432-F08F-47CD-9542-F77C427C9269

Q34220004-05205153-644B-4FB0-8CC5-AE3E79CE7D17

Q34220004-05969C98-2666-4D54-9D36-271ADB5935C3

Q34220004-06B4351E-7AB9-41F9-8FE1-1FAF290313FA

Q34220004-07EC40D7-532F-497A-A235-9FD3B367A8C6

Q34220004-0AA8E438-DCD3-4752-9161-8C3F79E09813

Q34220004-0D280DE2-8E6C-47AB-BE5D-4A2DF352FF37

Q34220004-0F3C19EE-2C2A-4326-8E03-186A417312FB

Q34220004-1257C31B-7402-4D6A-A13A-D5396C4D8781

Q34220004-1938B5F6-45FC-4BC6-B61A-CFA4BF680D41

P304

Q34220004-39FA44E8-09FA-4993-B3F5-41D0A69CE507

P31

Q34220004-2911BCF9-D753-4F69-B4F4-99B32E8DE7D4

P356

Q34220004-541ABB0B-8B7D-4B71-992D-AA1D3CD136FE

P433

Q34220004-EC2505A1-CE2A-42DB-BA20-760753E6786B

P478

Q34220004-AE0E1018-508A-43BF-B8B7-A3685441A4C6

P577

Q34220004-C9DBB6C5-2960-4AA7-BD22-A3377689C195

P5875

Q34220004-9361CADC-25E3-4A49-A5B2-61706B5BA296

P698

Q34220004-CC68068F-CCE9-42A5-99BC-843EF85E100A

P921

Q34220004-1DD74B11-6541-40AD-8043-04D94EA241E0

Q34220004-5D3EEF22-5372-4B54-A72B-FF88EE8437C2

Q34220004-7F982C07-E03E-4E82-B937-CA2CAA4742A1

P932

Q34220004-069B4570-0CA2-4B3E-AA68-B2BEDBC9BC96

P356

P1433

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

P1476

An update on the pharmacotherapy of attention-deficit/hyperactivity disorder in adults

@en

P2093

Jefferson Prince

http://www.w3.org/2001/XMLSchema#string

Nicholas R Morrison

http://www.w3.org/2001/XMLSchema#string

Timothy E Wilens

http://www.w3.org/2001/XMLSchema#string

P2860

A randomized controlled trial of a novel mixed monoamine reuptake inhibitor in adults with ADHD

Understanding attention-deficit/hyperactivity disorder from childhood to adulthood

The Worldwide Prevalence of ADHD: A Systematic Review and Metaregression Analysis

The intersection of attention-deficit/hyperactivity disorder and substance abuse

Misuse and Diversion of Stimulants Prescribed for ADHD: A Systematic Review of the Literature

Neuronal nicotinic receptor agonists for the treatment of attention-deficit/hyperactivity disorder: focus on cognition

The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication

Comparing the efficacy of medications for ADHD using meta-analysis

A pilot controlled clinical trial of ABT-418, a cholinergic agonist, in the treatment of adults with attention deficit hyperactivity disorder

Antidepressants in the treatment of adult attention-deficit hyperactivity disorder: a systematic review

P304

1443-1465

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/ERN.11.137

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2011-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51677926

http://www.w3.org/2001/XMLSchema#string

P698

21955201

http://www.w3.org/2001/XMLSchema#string

P921

attention deficit hyperactivity disorder

pharmacotherapy

P932

3229037

http://www.w3.org/2001/XMLSchema#string